DIFFERENTIAL TRANSACTIVATION POTENTIAL OF OCT1 AND OCT2 IS DETERMINED BY ADDITIONAL B-CELL-SPECIFIC ACTIVITIES

被引:49
|
作者
PFISTERER, P
ANNWEILER, A
ULLMER, C
CORCORAN, LM
WIRTH, T
机构
[1] ZENTRUM MOLEK BIOL HEIDELBERG,D-69120 HEIDELBERG,GERMANY
[2] ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,MELBOURNE,VIC 3050,AUSTRALIA
来源
EMBO JOURNAL | 1994年 / 13卷 / 07期
关键词
CELL TYPE-SPECIFIC TRANSCRIPTIONAL REGULATION; COFACTORS; OCT1; OCT2;
D O I
10.1002/j.1460-2075.1994.tb06429.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell type-specific transcriptional regulation is generally believed to be mediated by sequence-specific transcription factors that are specifically present in the corresponding cells. The interaction of the lymphoid-specific Oct2 transcription factor has been thought to be responsible for the B cell-specific activity of octamer-containing promoter and enhancer elements. Here we show that physiological concentrations of Oct2 do not suffice to generate octamer-dependent promoter activity in non-B cell lines. Furthermore, we have tested the activity of octamer-dependent promoter and enhancer elements in B cell lines that lack the endogenous Oct2 protein. Our results demonstrate that in these Oct2-deficient B cells the ubiquitous endogenous Oct1 protein is able to stimulate octamer-containing promoters to a level comparable with that of normal Oct2-positive B cells. However, reporter constructs bearing the octamer motif in a distal enhancer position are not stimulated by the Oct1 protein, but do require the presence of Oct2. The B cell-specific octamer-dependent promoter activity mediated by Oct1 correlates with the presence of a novel B cell-specific octamer-binding complex containing the Oct1 protein. From these results we conclude that B cells contain two different activities: one that interacts with both Oct1 and Oct2 and mediates promoter proximal activity of the octamer motif and a second that specifically interacts with Oct2 to confer function from a remote enhancer position.
引用
收藏
页码:1654 / 1663
页数:10
相关论文
共 50 条
  • [21] Novel OCT1 and OCT2 genetic variations-Potential link to metformin associated vitamin B12 deficiency during diabetes
    Green, Lewis A.
    Antoine, Daniel J.
    Mills, Tracy
    Nicholls, Glynis
    Park, B. Kevin
    Pirmohamed, Munir
    TOXICOLOGY, 2011, 290 (2-3) : 143 - 144
  • [22] The organic cation transporters OCT1 and OCT2 contain an allosteric cation inhibitor site.
    Koepsell, H
    UlzheimerTeuber, I
    Ulzheimer, J
    Arndt, P
    Gorboulev, V
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0259 - A0259
  • [23] Inhibitory interaction of 125 frequently prescribed drugs with the organic cation transporters OCT1 and OCT2
    Muench, K.
    Zolk, O.
    Monti, J.
    Maas, R.
    Fromm, M. F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S58 - S58
  • [24] Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
    Eriko Shikata
    Rei Yamamoto
    Hiroshi Takane
    Chiaki Shigemasa
    Tadasu Ikeda
    Kenji Otsubo
    Ichiro Ieiri
    Journal of Human Genetics, 2007, 52 : 117 - 122
  • [25] Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
    Shikata, Eriko
    Yamamoto, Rei
    Takane, Hiroshi
    Shigemasa, Chiaki
    Ikeda, Tadasu
    Otsubo, Kenji
    Ieiri, Ichiro
    JOURNAL OF HUMAN GENETICS, 2007, 52 (02) : 117 - 122
  • [26] PARA-AMINOSALICYLIC ACID (PAS) CHARACTERIZED AS A SUBSTRATE OF OCT1 AND OCT2 AND OAT1 AND OAT3 TRANSPORTER AND OCT1/2 POLYMORPHISM EFFECT, IN VITRO
    Parvez, M. D. Masud
    Jung, Jin-Ah
    Shin, Ho Jung
    Kaisar, Nazia
    Hasanuzzaman, M. D.
    Kim, Dong-Hyun
    Shin, Jae-Gook
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S102 - S102
  • [27] Of dogs and men: Cloning of dog OCT1 and OCT2 and comparative characterization with human and other known orthologs
    Falk, S.
    Meyer, M. J.
    Roemer, S.
    Geyer, J.
    Simm, S.
    Tzvetkov, M. V.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (SUPPL 1) : S46 - S47
  • [28] Inhibition of human OCT1, OCT2, MATE1, OAT1 and NTCP mediated uptake by pesticides
    Kuehne, A.
    Floerl, S.
    Halpape, R.
    Hagos, Y.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S72 - S73
  • [29] OCT2 TRANSACTIVATION FROM A REMOTE ENHANCER POSITION REQUIRES A B-CELL-RESTRICTED ACTIVITY
    ANNWEILER, A
    MULLERIMMERGLUCK, M
    WIRTH, T
    MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (07) : 3107 - 3116
  • [30] Analysis of OCT1, OCT2 and OCT3 gene polymorphisms among Type 2 diabetes mellitus subjects in Indian ethnicity, Malaysia
    Al-Ashoor, Sabah Ghasan Abood
    Ramachandran, Vasudevan
    Mat, Liyana Najwa Inche
    Mohamad, Nur Afiqah
    Mohamed, Mohd Hazmi
    Sulaiman, Wan Aliaa Wan
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (01) : 453 - 459